Trifluent Pharma, LLC – FDA Inspection, Jun 11, 2026

Record Details

This FDA Inspection record concerns Trifluent Pharma, LLC, with an inspection on June 11, 2026, issued by the Dallas District Office, covering human drugs.

Company: Trifluent Pharma, LLC
Inspection Date: June 11, 2026
Product Type: Human Drugs
Office: Dallas District Office
People: Kevin T. Nguyen (Company Rep)
Shanna N. Purdy (FDA Associated Person)

View Company Profile

ID · d5f40a12-b2a8-4235-961c-e9f80e59b2c6

Inspection Facts

Inspection number: 1321580
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued, view the record

FDA Citations

21 CFR 211.125(f)Procedures Written and Followed
21 CFR 211.25(a)GMP Training Frequency

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Trifluent Pharma, LLC

FDA Inspection

Trifluent Pharma, LLCJune 11, 2026